These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11094434)

  • 1. Physiologic role of interleukin-1 receptor antagonist.
    Arend WP; Gabay C
    Arthritis Res; 2000; 2(4):245-8. PubMed ID: 11094434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
    Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
    Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
    Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
    Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
    Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist.
    Arend WP
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):1-6. PubMed ID: 11357165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonism.
    Nikolic-Paterson DJ; Lan HY; Atkins RC
    Semin Nephrol; 1996 Nov; 16(6):583-90. PubMed ID: 9125803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1 beta/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients.
    Shingu M; Fujikawa Y; Wada T; Nonaka S; Nobunaga M
    Br J Rheumatol; 1995 Jan; 34(1):24-30. PubMed ID: 7881833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist gene therapy for arthritis.
    Krishnan BR
    Curr Opin Mol Ther; 1999 Aug; 1(4):454-7. PubMed ID: 11713759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels.
    Buchs N; di Giovine FS; Silvestri T; Vannier E; Duff GW; Miossec P
    Genes Immun; 2001 Jun; 2(4):222-8. PubMed ID: 11477478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-1 receptor antagonist and its delivery by gene transfer.
    Evans CH; Robbins PD
    Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
    Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
    Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
    J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.